Neurofibromatosis type 1 (NF1) is a neurogenetic disorder associated with visual-spatial problems, executive dysfunction, and language deficits, making patients experience social isolation, stigma, anxiety, and depression. Here, we explored NF1 patients’ lived experiences by conducting semi-structured, in-depth interviews with 21 NF1 patients and 16 care providers. The thematic analysis uncovered dimensions of NF1 patients’ social lives at different ecological levels, including their relationships with family, friends, teachers, coworkers, providers, and society. Positive dimensions of NF1 patients’ social life (e.g. familial support and sacrifice, responsibility, and self-sufficiency, supportive friends, and professors) counter negative dimensions (e.g. the vulnerability in sexual relationships, social interactions, discriminatory professors, misconceptions about abilities, appearance bias, internalized and social stigma, violence, and low self-esteem). Adaptive strategies used or suggested by NF1 patients at personal (e.g. supportive network, positive reframing, acceptance of their bodies) and social levels (e.g. psychological support, group therapy, public awareness, and governmental support) were identified.
AblonJ (2012) Social stigma in Neurofibromatosis 1. In: UpadhyayaMCooperDN (eds) Neurofibromatosis Type 1. Berlin, Heidelberg: Springer, pp.673–682.
2.
AdkinsK (2021) Self-help targeting body image among adults living with dermatological conditions: An evaluation of a brief writing intervention. DClinPsy Thesis, University of Sheffield. Available at: https://etheses.whiterose.ac.uk/29555/ (accessed 2 August 2023).
3.
BarkeJCoadJHarcourtD (2016) Parents’ experiences of caring for a young person with neurofibromatosis type 1 (NF1): A qualitative study. Journal of Community Genetics7(1): 33–39.
4.
BarkeJHarcourtDCoadJ (2014) ‘It’s like a bag of pick and mix – You don’t know what you are going to get’: Young people’s experience of neurofibromatosis Type 1. Journal of Advanced Nursing70(7): 1594–1603.
5.
BicudoNPde Menezes NetoBFda Silva de AvóLR, et al (2016) Quality of life in adults with neurofibromatosis 1 in Brazil. Journal of Genetic Counseling25(5): 1063–1074.
6.
BirchPFriedmanJM (2012) Quality of life in NF1. In: UpadhyayaMCooperDN (eds) Neurofibromatosis Type 1. Berlin, Heidelberg: Springer, pp.93–103.
7.
BraunVClarkeV (2021a) One size fits all? What counts as quality practice in (reflexive) thematic analysis?Qualitative Research in Psychology18(3): 328–352.
8.
BraunVClarkeV (2021b) To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Research in Sport Exercise and Health13(2): 201–216.
9.
BuhrmanMFredrikssonAEdströmG, et al (2013) Guided Internet-delivered cognitive behavioural therapy for chronic pain patients who have residual symptoms after rehabilitation treatment: Randomized controlled trial. European Journal of Pain17(5): 753–765.
10.
BuonoFDSprongMEPaulE, et al (2021) The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1. Orphanet Journal of Rare Diseases16(1): 234.
11.
Burkitt WrightEMSachESharifS, et al (2013) Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. Journal of Medical Genetics50(9): 606–613.
12.
CannonAChenM-JLiP, et al (2018) Cutaneous neurofibromas in Neurofibromatosis type I: A quantitative natural history study. Orphanet Journal of Rare Diseases13(1): 31.
13.
ChirindelAChaudhryMBlakeleyJO, et al (2015) 18F-FDG PET/CT qualitative and quantitative evaluation in Neurofibromatosis type 1 patients for detection of malignant transformation: Comparison of early to delayed imaging with and without liver activity normalization. World Journal of Nuclear Medicine56(3): 379–385.
14.
CohenJSLevyHPSloanJ, et al (2015) Depression among adults with Neurofibromatosis type 1: Prevalence and impact on quality of life. Clinical Genetics88(5): 425–430.
15.
CooleyCH (2022) The Production of Reality: Essays and Readings on Social Interaction, 7th edn.London; Washington, DC: Sage.
16.
CooleyCHRieffPMeadH (1964) Human Nature and the Social Order. New York, NY: Schocken Books.
17.
Copley-MerrimanCYangXJuniperM, et al (2021) Natural history and disease burden of Neurofibromatosis type 1 with plexiform neurofibromas: A systematic literature review. Adolescent Health Medicine and Therapeutics12: 55–66.
18.
CorbinJStraussA (2008) Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory, 3rd edn.Thousand Oaks, CA: Sage Publications, Inc.
19.
CostanzaARadomskaMBondolfiG, et al (2021) Suicidality associated with deep brain stimulation in extrapyramidal diseases: A critical review and hypotheses on neuroanatomical and neuroimmune mechanisms. Frontiers in Integrative Neuroscience15: 632249.
20.
DonnellCMMizelleNDZhengY (2009) Consumers of vocational rehabilitation services diagnosed with psychiatric and substance use disorders. Journal of Rehabilitation75(3): 41–49.
21.
DoserKKenborgLAndersenEW, et al (2019) Educational delay and attainment in persons with neurofibromatosis 1 in Denmark. European Journal of Human Genetics27(6): 857–868.
22.
DrauckerCBNutakkiKVarniJW, et al (2017) The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives. Journal for Specialists in Pediatric Nursing22: e12174.
23.
FernerRE (2007) Neurofibromatosis 1 and neurofibromatosis 2: A twenty-first century perspective. Lancet Neurology6: 340–351.
24.
FernerREThomasMMercerG, et al (2017) Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Health and Quality of Life Outcomes15(1): 34.
25.
FjermestadKW (2019) Health complaints and work experiences among adults with neurofibromatosis 1. Occupational Medicine69(7): 504–510.
26.
FojiSMohammadiESanagooA, et al (2021a) Experience of patients with neurofibromatosis: A qualitative research. Journal of Nursing and Midwifery Sciences8(3): 163.
27.
FojiSMohammadiESanagooA, et al (2021b) The patients’ experiences of burden of neurofibromatosis: A qualitative study. Iranian Journal of Nursing and Midwifery Research26(4): 342–348.
28.
FournierHCalcagniNMorice-PicardF, et al (2023) Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: A systematic review. Orphanet Journal of Rare Diseases18(1): 39.
29.
FredricksonBLRobertsT-A (1997) Objectification theory: Toward understanding women’s lived experiences and mental health risks. Psychology of Women Quarterly21(2): 173–206.
30.
Goetsch WeismanAHawsTLeeJ, et al (2023) Transition readiness assessment in adolescents and young adults with Neurofibromatosis Type 1 (NF1). Comprehensive Child and Adolescent Nursing46(3): 223–239.
31.
GoffmanE (1986) Stigma: Notes on the Management of Spoiled Identity, 1. Touchstone edn. New York, NY: Simon & Schuster.
32.
GrafALandoltMAMoriAC, et al (2006) Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. The Journal of Pediatrics149(3): 348–353.
33.
GranströmSLangenbruchAAugustinM, et al (2012) Psychological burden in adult neurofibromatosis type 1 patients: Impact of disease visibility on body image. Dermatology224(2): 160–167.
34.
GuestGBunceAJohnsonL (2006) How many interviews are enough? An experiment with data saturation and variability. Field Methods18(1): 59–82.
35.
Hamoy-JimenezGKimRSuppiahS, et al (2020) Quality of life in patients with neurofibromatosis type 1 and 2 in Canada. Neuro-oncology Advances2(Suppl 1): i141–i149.
36.
HymanSLArthur ShoresENorthKN (2006) Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology48(12): 973–977.
37.
JohnsonNSSaalHMLovellAM, et al (1999) Social and emotional problems in children with neurofibromatosis type 1: Evidence and proposed interventions. The Journal of Pediatrics134(6): 767–772.
38.
KinchJW (1963) A formalized theory of the self-concept. The American Journal of Sociology68(4): 481–486.
39.
Klein-TasmanBPColonAMBreiN, et al (2013) Adaptive behavior in young children with neurofibromatosis type 1. International Journal of Pediatrics2013: 1–7.
40.
KonradiA (2021) Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry. BMC Pediatrics21(1): 173.
41.
KrabLCAarsenFKde Goede-BolderA, et al (2008) Impact of neurofibromatosis type 1 on school performance. Journal of Child Neurology23(9): 1002–1010.
42.
LaiJ-SJensenSEPatelZS, et al (2017) Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan. American Journal of Medical Genetics. Part A173(1): 79–87.
43.
LehtonenAHowieETrumpD, et al (2013) Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence. Developmental Medicine and Child Neurology55(2): 111–125.
44.
LysaghtRFabrigarLLarmour-TrodeS, et al (2012) Measuring workplace social support for workers with disability. Journal of Occupational Rehabilitation22(3): 376–386.
45.
MahajanAPatvekarMLoteS, et al (2022) A clinico-epidemiological study of Neurofibromatosis type 1 and its relation to quality of life: A cross-sectional study from India. Cureus14(2): e22376.
46.
MartinSStruemphKLPobleteA, et al (2018) An Internet support group for parents of children with neurofibromatosis type 1: A qualitative analysis. Journal of Community Genetics9(3): 327–334.
47.
MartinSWoltersPLBaldwinA, et al (2014) Attitudes about Internet support groups among adolescents and young adults with Neurofibromatosis type 1 and their parents. Journal of Genetic Counseling23(5): 796–804.
48.
MartinSWoltersPLToledo-TamulaMA, et al (2016) Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy. American Journal of Medical Genetics. Part A170(6): 1462–1470.
49.
MeadGH (1934) Mind, Self, and Society From the Standpoint of a Social Behaviorist. Chicago, IL: University of Chicago Press.
50.
NollRBReiter-PurtillJMooreBD, et al (2007) Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics. Part A 143A(19): 2261–2273.
51.
NowickiA-R (2019) Enfreakment: Disability as narrative spectacle in Theodor Storm’s ‘Eine Malerarbeit’ and Marie von Ebner-Eschenbach’s ‘Die arme Kleine’. Feminist German Studies35(1): 26–52.
52.
PepeFSantoroPMonteleoneM (2021) Reproductive issues in Neurofibromatosis type 1: An update. Archives of Obstetrics and Gynaecology2(3): 79–86.
53.
RichardsonN (2017) The Routledge Companion to Media, Sex and Sexuality, 1st edn. London: Routledge.
54.
RietmanABvan HeldenHBothPH, et al (2018) Worries and needs of adults and parents of adults with neurofibromatosis type 1. American Journal of Medical Genetics. Part A176(5): 1150–1160.
55.
RusliBNEdimansyahBANaingL (2008) Working conditions, self-perceived stress, anxiety, depression and quality of life: A structural equation modelling approach. BMC Public Health8(1): 48.
56.
SanagooAJouybariLKoohiF, et al (2019) Evaluation of QoL in neurofibromatosis patients: A systematic review and meta-analysis study. BMC Neurology19(1): 123.
57.
SerpeRTStrykerS (2011) The symbolic interactionist perspective and identity theory. In: SchwartzSLuyckxKVignolesV (eds) Handbook of Identity Theory and Research, vols. 1 and 2. New York, NY: Springer Science + Business Media, pp.225–248.
58.
SharrattNDJenkinsonEMossT, et al (2018) Understandings and experiences of visible difference and romantic relationships: A qualitative exploration. Body Image27: 32–42.
59.
SilvaCSCalheirosMM (2022) Youth’s self-construction in the context of residential care: The looking-glass self within the youth-caregiver relationship. Children and Youth Services Review132: 106328.
60.
SmithKBWangDLPlotkinSR, et al (2013) Appearance concerns among women with neurofibromatosis: Examining sexual/bodily and social self-consciousness. Psycho-Oncology22(12): 2711–2719.
TruskettPG (2015) Bullying and harassment and ‘the looking glass self’. ANZ Journal of Surgery85(7–8): 498–498.
63.
Van LangePAHigginsETKruglanskiAW (2011) Handbook of Theories of Social Psychology. London: Sage Publications Ltd, pp.1–568.
64.
Van LierdeAMenniFBedeschiMF, et al (2013) Healthcare transition in patients with rare genetic disorders with and without developmental disability: Neurofibromatosis 1 and Williams–Beuren syndrome. American Journal of Medical Genetics. Part A 161A(7): 1666–1674.
65.
VranceanuA-MMerkerVLParkE, et al (2013) Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: A systematic review of the literature. Journal of Neuro-Oncology114(3): 257–262.
66.
VranceanuA-MMerkerVLParkER, et al (2015) Quality of life among children and adolescents with neurofibromatosis 1: A systematic review of the literature. Journal of Neuro-Oncology122(2): 219–228.
67.
ZebrowitzLAMontepareJM (2008) Social psychological face perception: Why appearance matters. Social and Personality Psychology Compass2(3): 1497.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
